Roche ' s Tocilizumab Cuts Deaths in Hospitalized COVID-19 Patients: Study Roche ' s Tocilizumab Cuts Deaths in Hospitalized COVID-19 Patients: Study

Roche ' s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, results of a large trial showed on Thursday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news